Patents
Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
03/2011
03/08/2011US7901708 Liposomal apparatus and manufacturing methods
03/03/2011WO2010101526A9 A diguanylate cyclase, method of producing the same and its use in the manufacture of cyclic-di-gmp and analogues thereof
03/03/2011US20110054165 Xanthene dyes
03/03/2011US20110054164 Production process of ethynylthymidine compounds from 5-methyluridine as a starting material
03/03/2011US20110054163 P2y6 receptor agonists for treating lung diseases
03/03/2011US20110053883 Agent that modulates physiological condition of pests, involved in insect c-jun amino-terminal kinase activity
03/03/2011US20110053881 6-Disubstituted Or Unsaturated Bicyclic Nucleic Acid Analogs
03/03/2011US20110053282 Methods and Kits Using Extended Rhodamine Dyes
03/03/2011US20110053154 2'-nitrobenzyl-modified ribonucleotides
03/02/2011EP2290098A1 Preparing crude biological extracts using protease, suitable for preparing cDNA
03/02/2011EP2290078A2 Immunostimulatory nucleic acids
03/02/2011EP2066685B1 Novel 2',3'-methylidene acetyl adenosine prodrugs for use as prodrugs for adenosine receptor agonists
03/02/2011EP2040712B1 Carbonate and carbamate prodrugs of thiazolo [4,5-d] pyrimidines
03/02/2011CN101168554B Method for preparing 18F-FLT
03/01/2011US7897759 Metabolically stable puromycin analogs
03/01/2011US7897737 Polymorphic identification; fluorescent dyes
03/01/2011US7897736 Fluorescent quenching detecting reagents and methods
03/01/2011US7897346 Polyamide nucleic acid derivatives and agents, and processes for preparing them
02/2011
02/24/2011WO2011022712A1 Method of treating infectious mononucleosis with acylic nucleoside derivatives
02/24/2011WO2011020298A1 Process for the preparation of cladribine
02/24/2011US20110046363 Process for the Preparation of Cladribine
02/24/2011US20110046362 Methods of making nucleoside tetraphosphate
02/24/2011US20110046082 Deuterium-enriched nelarabine
02/24/2011US20110045585 Kit for fluorometric analysis
02/24/2011US20110045535 Activator for Blood Coagulation Factor VII Promoter and Utilization of the Same
02/24/2011US20110044904 Crystal forms of 2--adenosine
02/23/2011CN101979398A Thymine compound and application thereof as molecular probe target material
02/23/2011CN101979397A HCV nucleoside inhibitor
02/22/2011US7893227 Polymorphic identification; fluorescent dyes
02/22/2011US7893084 Viral polymerase inhibitors
02/22/2011US7892518 fluorinating a specific position of a saccharide substrate selectively without affecting a protective group at a temperature within a wide range safely and easily with N, N-diethyl-alpha, alpha-difluoro(3-methyl)benzylamine a fluorinating agent under irradiation with microwave or electromagnetic wave
02/17/2011WO2011019031A1 Method and reagent for gene sequence analysis
02/17/2011US20110040083 Photoresponsive nucleic acid manufacturing method
02/17/2011US20110040082 Modifications of antimetabolite gemcitabine for incorporation in CpG oligonucleotides
02/17/2011US20110039799 A1 adenosine receptor agonist polymorphs
02/17/2011US20110039798 Substituted nucleoside derivatives with antiviral and antimicrobial properties
02/17/2011US20110039797 Oligomer Conjugates of Heteropentacyclic Nucleosides
02/17/2011US20110039266 Flowcell systems for single molecule detection
02/17/2011US20110039259 Dna sequence with non-fluorescent nucleotide reversible terminators and cleavable label modified nucleotide terminators
02/17/2011US20110038833 Modified fluorinated nucleoside analogues
02/16/2011CN101977923A Novel cytostatic 7-deazapurine nucleosides
02/16/2011CN101977610A Methods of treating viral infections
02/16/2011CN101974051A Method for synthesizing azacitidine
02/16/2011CN101972669A Nucleoside preparation technology by using solvent-free melting method and catalyst used thereby
02/16/2011CN101475621B Method for purifying clofarabine by using chromatographic column
02/16/2011CN101111509B Novel pyrimidine nucleoside compound or its salt
02/15/2011US7888507 UV excitable fluorescent energy transfer dyes
02/15/2011US7888330 Phosphoramidate derivatives of FAU
02/15/2011US7888136 Comprises benzazolium, pyridinium, or quinolinium connected by methine bridge; reporter molecules for detection of RNA in presence of DNA; solid phase synthesis; kits
02/15/2011CA2628883C Novel 3'-modified oligonucleotide derivatives
02/15/2011CA2438202C Salts of avermectins substituted in the 4"-position and having pesticidal properties
02/15/2011CA2416757C Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same
02/10/2011WO2011017253A1 Composition and methods of treating viral infections and viral induced tumors
02/10/2011US20110034522 Methods for alleviating deleterious effects of 3-deoxyglucosone
02/09/2011EP2280973A1 Carba-nucleoside analogs for antiviral treatment
02/09/2011EP1943251B1 A1 adenosine receptor agonists
02/09/2011CN101107261B Imidazopyridine derivative
02/08/2011US7884202 Nucleobases are perfluoroalkylated in a one step process with a perfluoroalkyl halide in the presence of a sulfoxide, a peroxide and an iron compound; useful as medicinal drugs, intermediates for medicinal drugs and agricultural chemicals
02/08/2011US7884053 Methods, kits and compositions pertaining to combination oligomers and libraries for their preparation
02/08/2011US7883869 for sequencing single-stranded DNA by employing a nanopore and modified nucleotides
02/08/2011CA2341574C Phosphohalohydrins, method for making same and uses
02/03/2011US20110028706 Inosine derivatives and production methods therefor
02/03/2011US20110028705 Method for the stereoselective synthesis of phosphorus compounds
02/03/2011US20110028423 Agent that modulates physiological condition of pests, involved in insect choline acetyltransferase activity
02/03/2011US20110028350 Photocleavable protecting groups
02/03/2011US20110027360 Pharmacokinetics of s-adenosylmethionine formulations
02/02/2011EP2279755A2 Remodelling and glycoconjugation of Fibroblast Growth Factor (FGF)
02/02/2011EP2279754A2 Remodelling and glycoconjugation of human growth hormone (hGH)
02/02/2011EP2279753A2 Remodeling and glycoconjugation of peptides
02/02/2011EP2279194A1 Unnatural polymerase substrates that can sustain enzymatic synthesis of double stranded nucleic acids from a nucleic acid template and methods of use
02/02/2011EP2279193A1 Novel triazole derivatives, their preparation and their application in therapeutics
02/02/2011CN101962397A Method for separating and purifying 2'-deoxyadenosine from biotransformation liquid
02/02/2011CN101962390A Fluorescently tagged ligands
02/01/2011US7879986 quenchers of excited state energy have a structure comprising at least one reactive functional group for linking the quencher to a carrier molecule and at least three radicals covalently linked via exocyclic diazo bonds, the three radicals including at least one comprising a julolidine
02/01/2011US7879814 Administering adenosine 5'-monophosphate; side effect reduction
02/01/2011US7879580 Methods for high fidelity production of long nucleic acid molecules
02/01/2011US7879554 Electrochemical method to measure DNA attachment to an electrode surface in the presence of molecular oxygen
02/01/2011CA2388369C Novel oligosaccharides, preparation method and pharmaceutical compositions containing same
01/2011
01/27/2011WO2011010967A1 Process for producing flurocytidine derivatives
01/27/2011US20110021769 Process for Producing Fluorocytidine Derivatives
01/27/2011US20110021454 Modified 4`-nucleosides as antiviral agents
01/27/2011US20110021365 Nucleic Acid Binding Compounds Containing Pyrazolo[3,4-D]Pyrimidine Analogues of Purin-2,6-Diamine and Their Uses
01/27/2011US20110020827 Modified nucleosides and nucleotides and uses thereof
01/26/2011EP2277885A1 Glycosylated indolecarbazoles, method for obtaining same and uses thereof
01/26/2011EP2277878A1 Process for production of ethynylthymidine compound using 5-methyluridine as starting raw material
01/26/2011EP2276774A2 Therapeutic substances that modulate genome methylation
01/26/2011EP2034834B1 Prodrugs of 5-amino-3-(3'-deoxy-beta-d-ribofuranosyl)-thiazolo[4,5-d]pyrimidin-2,7-dione
01/26/2011CN101240002B Fatty acylaminoacylcytarabine conjugate, preparation method and application thereof
01/26/2011CN101024667B Method for preparing gemcitabine hydrochloride
01/25/2011US7875604 Compounds that inhibit HIV particle formation
01/20/2011WO2010018438A3 Tetrazole glycosides
01/20/2011US20110015384 Sulfurization agent and its use
01/20/2011US20110015383 Derivatives of nucleoside-5'-o-hypophosphates and their mono- and dithiohypophosphate analogues and the process for the manufacture thereof
01/20/2011US20110015382 Synthesis of N-FMOC protected deoxy nucleosides, ribo nucleosides, modified deoxy and ribo nucleosides, and phosphoramidites, and their use in oligonucleotide synthesis
01/20/2011US20110015148 Antiviral nucleosides
01/20/2011US20110015147 Anti-viral pyrimidine nucleoside analogues
01/20/2011US20110015146 Nucleoside phosphoramidates
01/20/2011US20110015145 Cladribine formulations for improved oral and transmucosal delivery
01/20/2011US20110014611 Design and synthesis of cleavable fluorescent nucleotides as reversible terminators for dna sequences by synthesis
01/20/2011US20110014216 Drug Transfer Based on Coenzyme A and Acyl Carrier Protein
1 ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 ... 201